Kura Oncology Stock (NASDAQ: KURA) stock price, news, charts, stock research, profile.
Open | $20.52 |
Close | - |
Volume / Avg. | 164.26K / 717.97K |
Day Range | 20.38 - 20.83 |
52 Wk Range | 7.41 - 24.17 |
Market Cap | $1.57B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 11.8% |
Days to Cover | 15.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kura Oncology (NASDAQ:KURA) through any online brokerage.
Other companies in Kura Oncology’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
There is no analysis for Kura Oncology.
Kura Oncology has a consensus price target of $28.63.
The stock price for Kura Oncology (NASDAQ: KURA) is $20.36 last updated July 24, 2024 at 4:30 PM EDT.
There are no upcoming dividends for Kura Oncology.
Kura Oncology’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Kura Oncology.
Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.